Clearmind Medicine Inc (CMND)
1.23
-0.06
(-4.65%)
USD |
NASDAQ |
May 17, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Total Assets (Quarterly): 10.10M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 10.10M |
| October 31, 2023 | 4.305M |
| July 31, 2023 | 3.386M |
| April 30, 2023 | 4.390M |
| January 31, 2023 | 4.643M |
| October 31, 2022 | 0.6072M |
| July 31, 2022 | 0.8845M |
| April 30, 2022 | 1.605M |
| January 31, 2022 | 2.554M |
| October 31, 2021 | 4.163M |
| July 31, 2021 | 5.660M |
| April 30, 2021 | 1.600M |
| Date | Value |
|---|---|
| January 31, 2021 | 0.3386M |
| October 31, 2020 | 0.3848M |
| July 31, 2020 | 0.4392M |
| April 30, 2020 | 0.4836M |
| January 31, 2020 | 0.1347M |
| October 31, 2019 | 0.1355M |
| July 31, 2019 | 0.144M |
| April 30, 2019 | 0.1556M |
| January 31, 2019 | 0.1666M |
| October 31, 2018 | 0.1881M |
| July 31, 2018 | 0.1916M |
| April 30, 2018 | 0.2303M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1347M
Minimum
Jan 2020
10.10M
Maximum
Jan 2024
2.419M
Average
1.600M
Median
Apr 2021
Total Assets (Quarterly) Benchmarks
| SciSparc Ltd | 11.18M |
| ImmunoPrecise Antibodies Ltd | 58.71M |
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.056M |
| Shareholders Equity (Quarterly) | 5.041M |